Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer's disease

GLIA

Volumn 64, Issue 9, 2016, Pages 1562-1572

  Tischer, Jasmin ^a   Krueger, Martin ^a   Mueller, Wolf ^b   Staszewski, Ori ^c   Prinz, Marco ^d   Streit, Wolfgang J ^e   Bechmann, Ingo ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c Institute of Neuropathology   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; cytorrhexis; glial pathology; Iba 1; microglia; neurodegeneration; senescence

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CD68 ANTIGEN; HLA DR ANTIGEN; INTRACELLULAR CALCIUM BINDING PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DYSTROPHY; ELECTRON MICROSCOPY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROPATHOLOGY; PRIORITY JOURNAL; VERY ELDERLY;

EID: 84978946801     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23024     Document Type: Article

References (67)

1. ADAPT Research Group (2008) Cognitive Function over time in the Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)—Results of a randomized, controlled trial of Naproxen and Celecoxib. Arch Neurol. 65:896–905.
2. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study. 2003. Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: A randomized controlled trial. JAMA 289:2819–2826.
3. Babcock AA, Kuziel WA, Rivest S, Owens T. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23:7922–7930.
4. Bachstetter AD, Van Eldik LJ, Schmitt FA, Neltner JH, Ighodaro ET, Webster SJ, Patel E, Abner EL, Kryscio RJ, Nelson PT. 2015. Disease-related microglia heterogeneity in hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun 3:32-
5. Bechmann I, Goldman J, Kovac AD, Kwidzinski E, Simbürger E, Naftolin F, Dirnagl U, Nitsch R. 2005. Circulating monocytic cells infiltrate layers of anterograde axonal degeneration where they transform into microglia. FASEB J 19:647–649.
6. Bruttger J, Karram K, Wörtge S, Regen T, Marini F, Hoppmann N, Klein M, Blank T, Yona S, Wolf Y, Mack M, Pinteaux E, Müller W, Zipp F, Binder H, Bopp T, Prinz M, Jung S, Waisman A. 2015. Genetic cell ablation reveal clusters of local self renewing microglia in the mammalian central nervous system. Immunity 43:92–106.
7. Cho SH, Sun, B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. 2011. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem 286:32713–32722.
8. Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW. 2012. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: A microarray study. J Neuroinflammation 9:179
9. Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN. 2014. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking as microglia progenitor cell in the adult brain. Neuron 82:380–397.
10. Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermöhlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M. 2015. Host microbiiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18:965–977.
11. Farso M, Ménard C, Colby-Milley J, Quirion R. 2013. The immune marker CD68 correlates with cognitive impairment in normally aged rats. Neurobiol Aging 34:1971–1976.
12. Fendrick SE, Xue QS, Streit WJ. 2007. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide-dismutase gene. J Neuroinflammation 4:9
13. Frank S, Burbach GJ, Bonin M, Walter M, Streit WJ, Bechmann I, Deller T. 2008. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56:1438–1447.
14. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhavlov IM, Merad M. 2010. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841–845.
15. Gonzàlez H, Pacheco R. 2014. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation 11:201
16. Graeber MB, Streit WJ. 1990. Microglia: Immune network in the CNS. Brain Pathol 1:2–5.
17. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis Group. 2013. TREM2 variants in Alzheimer's disease. N Engl J Med 368:117–127.
18. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387–1394.
19. Hart AD, Wyttenbach A, Perry VH, Teeling JL. 2012. Age related changes in microglial phenotype vary between CNS regions: Grey versus white matter differences. Brain Behave Immun 26:754–765.
20. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O'Branion K, Klockgether T, Van Leuven F, Landreth GE. 2005. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128:1442–1453.
21. Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D. 2015. Systemic inflammation and microglial activation: Systematic review of animal experiments. jni 12:114-
22. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. 1989. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J Neuroimmunol 24:173–182.
23. Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL, Cotleur AC, Butovsky O, Bekris L, Staugaitis SM, Leverenz JB, Pimplikar SW, Landreth GE, Howell GR, Ransohoff RM, Lamb BT. 2015. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 212:287–95.
24. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, JOnsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K. 2013. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368:107–116.
25. Kawashima K, Fujii T, Moriwaki Y, Misawa H. 2012. Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci 91:1027–1032.
26. Khan AM, Babcock AA, Saeed H, Myhre CL, Kassem M, Finsen B. 2015. Telomere dysfunction reduces microglial numbers without fully inducing an aging phenotype. Neurobiol Aging 36:2164–2175.
27. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Hölscher C, Müller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geissmann F, Rosenbauer F, Prinz M. 2013. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 16:273–280.
28. Korotzer AR, Pike CJ, Cotman CW. 1993. Beta-amyloid peptides induce degeneration of cultured rat microglia. Brain Res 624:121–125.
29. Krabbe G, Halle A, Matyash V, Rinnenthal JL, Eom GD, Bernhardt U, Miller KR, Prokop S, Kettenmann H, Heppner FL. 2013. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One 8:e60921-
30. Kreuzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 8:312–318.
31. Lemstra AW, Groen in't Woud JC, Hoozemans JJ, van Haastert ES, Rezemuller AJ, Eikelenboom P, van Gool WA. 2007. Microglia activation in sepsis: A case-control study. J Neuroinflammation 4:4-
32. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J. 2001. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35:72–79.
33. Ma L, Morton AJ, Nicholson LF. 2003. Microglia density decreases with age in a mouse model of Huntingtons disease. Glia 43:274–280.
34. McGeer PL, Itagaki S, Tago H, McGeer EG. 1987. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the HLA-DR. Neurosci Lett 79:195–200.
35. Mestas J, Hughes CCW. 2004. Of mice and not man: Differences between mouse and human immunology. J Immunol 172:2731–2738.
36. hiCCR2+ monocytes only under defined host conditions. Nat Neurosci 10:1544–1553.
37. Mildner A, Schlevogt B, Kierdorf K, Böttcher C, Erny D, Kummer MP, Quinn M, Brück W, Bechmann I, Heneka MT, Priller J, Prinz M. 2011. Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci 31:11159–71.
38. Neumann H, Kotter MR, Franklin RJ. 2009. Debris clearance by microglia: An essential link between degeneration and regeneration. Brain 132:288–295.
39. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–8.
40. Ohm TG, Müller H, Braak H, Bohl J. 1995. Close-meshed prevelance rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 64:209–217.
41. Perry VH, Matyszak MK, Fearn S. 1993. Altered antigen expression of microglia in the aged rodent CNS. Glia 7:60–67.
42. Perry VH, Teeling J. 2013. Microglia and macrophages of the central nervous system: The contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol 35:601–612.
43. Priller J, Flügel A, Wehner T, Boentert M, Haas CA, Prinz M, Fernández-Klett F, Prass K, Bechmann I, de Boer BA, Frotscher M, Kreutzberg GW, Persons DA, Dirnagl U. 2001. Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment. Nat Med 7:1356–1361.
44. Radde R, Duma C, Goedert M, Jucker M. 2008. The value of incomplete mouse models of Alzheimer's disease. Eur J Nucl Med Mol Imaging 35:S70–S74.
45. Ransohoff RM, Perry VH. 2009. Microglial physiology: Unique stimuli, specialized responses. Annu Rev Immunol 27:119–145.
46. Rivera J, Tessarollo L. 2008. Genetic background and the dilemma of translating mouse studies to humans. Immunity 28:1-
47. Rogers J, Luber-Narod J, Styren SD, Civin WH. 1988. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9:339–349.
48. Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N. 1999. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology 53:197–201.
49. Schneemann M, Schoeden G. 2007. Macrophage biology and immunology: Man is not a mouse. J Leukoc Biol 81:579-
50. Simmons DA, Casale M, Alcon B, Pham N, Narajan N, Lynch G. 2007. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55:1074–1084.
51. Stieler JT, Lederer C, Brückner MK, Wolf H, Holzer M, Gertz HJ, Arendt T. 2001. Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease. Neuroreport 12:3969–72.
52. Stieler J, Grimes R, Weber D, Gartner W, Sabbagh M, Arendt T. 2012. Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease. Neurobiol Aging 3:234–241.
53. Streit WJ, Sammons NW, Kuhns AJ, Sparks DL. 2004. Dystrophic microglia in the aging human brain. Glia 45:208–212.
54. Streit WJ. 2005. Microglia and neuroprotection:implications for Alzheimer's disease. Brain Res Brain Res Rev 48:234–239.
55. Streit WJ. 2006. Microglial senescence: Does the brain's immune system have an expiration date? Trends Neurosci 9:506–510.
56. Streit WJ, Braak H, Xue QS, Bechmann I. 2009. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118:475–485.
57. Streit WJ. 2010. Microglial activation and neuroinflammation in Alzheimer's disease: A critical examination of recent history. Front Aging Neurosci 2:22
58. Streit WJ, Xue QS. 2010. The brain's immune system. Aging Dis 1:254–261.
59. Streit WJ, Xue QS, Tischer J, Bechmann I. 2014. Microglial pathology. Acta Neuropathol Commun 2:142-
60. Takahashi K, Rochford CD, Neumann H. 2005. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647–657.
61. Trapp BD, Wujek JR, Criste GA, Jalabi W, Yin X, Kidd GJ, Stohlman S, Ransohoff R. 2007. Evidence for Synaptic Stripping by Cortical Microglia. Glia 55:360–368.
62. Wang L, Xie Y, Zhu LJ, Chang TT, Mao YQ, Li J. 2010. An association between immunosenescence and CD4+CD25+ regulatory T cells: A systematic review. Biomed Environ Sci 23:327–332.
63. Wang J, Tan L, Wang HF, Tan CC, Meng XF, Wang C, Tang SW, Yu JT. 2015. Anti-inflammatory drugs and risk of Alzheimer's disease: An updated systematic review and meta-analysis. J Alzheimers Dis 44:385–396.
64. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH. 2001. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414:212–216.
65. Wirenfeldt M, Dissing-Olesen L, Anne Babcock A, Nielsen M, Meldgaard M, Zimmer J, Azcoitia I, Leslie RG, Dagnaes-Hansen F, Finsen B. 2007. Population control of resident and immigrant microglia by mitosis and apoptosis. Am J Pathol 171:617–631.
66. Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G. 2003. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci 23:7504–7509.
67. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M. 2006. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9:268–275.